EX-99.1 2 ea021374201ex99-1_oruka.htm JOINT FILING AGREEMENT

Exhibit 99.1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock, $0.001 par value per share, of Oruka Therapeutics, Inc. and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filing.

 

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13D and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

 

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

 

Date: September 6, 2024 

 

FAIRMOUNT FUNDS MANAGEMENT LLC
     
By: /s/ Peter Harwin   /s/ Tomas Kiselak
  Peter Harwin   Tomas Kiselak
  Managing Member   Managing Member

 

FAIRMOUNT HEALTHCARE FUND II L.P.
     
By: /s/ Peter Harwin   /s/ Tomas Kiselak
  Peter Harwin   Tomas Kiselak
  Managing Member   Managing Member

 

FAIRMOUNT HEALTHCARE CO-INVEST III L.P.
 
/s/ Peter Harwin   /s/ Tomas Kiselak
Peter Harwin   Tomas Kiselak
Managing Member   Managing Member

 

/s/ Peter Harwin    
Peter Harwin    
     
/s/ Tomas Kiselak    
Tomas Kiselak